MedTrace Logo

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

NCT00946829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18299

Last updated 2019-11-05

No results posted yet for this study

Summary

The aim of the observational study is to ascertain the degree of blood pressure control in the early-morning hours after 8 weeks of treatment with Telmisartan/Telmisartan+Hydrochlorothiazide and during 44 weeks of follow-up, in patients with hypertension using home blood pressure measurements.

Conditions

Interventions

DRUG

telmisartan

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2007-05-31

Countries

  • Belgium
  • Canada
  • Colombia
  • Czechia
  • Ecuador
  • Indonesia
  • Jordan
  • Lebanon
  • Mexico
  • Turkey (Türkiye)
  • Venezuela
  • Yemen

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946829 on ClinicalTrials.gov